Skip to main content
Clinical Trials/NCT06489080
NCT06489080
Recruiting
Not Applicable

Survival and cArdiovascular eVents in Patients With Acute Myocardial Infarction in Peking UNiversity First Hospital: A lonG-term Cohort Study

Peking University First Hospital1 site in 1 country10,000 target enrollmentMarch 1, 2024

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Acute Myocardial Infarction
Sponsor
Peking University First Hospital
Enrollment
10000
Locations
1
Primary Endpoint
Major Adverse Cardiovascular Events
Status
Recruiting
Last Updated
last year

Overview

Brief Summary

This prospective and prospective cohort study aims to establish a long-term follow-up cohort of patients with acute myocardial infarction, and combine multi-omics studies, wearable devices, artificial intelligence technology, etc., to describe the clinical characteristics of patients with acute myocardial infarction and the changing trend of treatment strategies, and analyze the related influencing factors. Explore new biomarkers and indicators affecting recurrent cardiovascular events for accurate risk stratification and risk prediction; To evaluate the factors affecting lifestyle intervention, drug efficacy and safety, and their impact on outcome, and improve chronic disease management mode, in order to improve the quality of life and prognosis of patients.

Registry
clinicaltrials.gov
Start Date
March 1, 2024
End Date
December 31, 2028
Last Updated
last year
Study Type
Observational
Sex
All

Investigators

Responsible Party
Principal Investigator
Principal Investigator

Jianping LI

Director of Department of Cardiology

Peking University First Hospital

Eligibility Criteria

Inclusion Criteria

  • Acute myocardial infarction is diagnosed meets the universal definition of acute myocardial infarction

Exclusion Criteria

  • Did not agree to participate in the study

Outcomes

Primary Outcomes

Major Adverse Cardiovascular Events

Time Frame: 5 years

Composite end points of Cardiovascular death, nonfatal myocardial infarction, nonfatal ischemic stroke

Secondary Outcomes

  • Secondary Adverse Cardiovascular Events(5 years)

Study Sites (1)

Loading locations...

Similar Trials